HSDB 419 en es it fr

HSDB 419 Brand names, HSDB 419 Analogs

HSDB 419 Brand Names Mixture

  • No information avaliable

HSDB 419 Chemical_Formula

As2O3

HSDB 419 RX_link

http://www.rxlist.com/cgi/generic2/arsenic.htm

HSDB 419 fda sheet

HSDB_419 FDA

HSDB 419 msds (material safety sheet)

HSDB 419 Synthesis Reference

No information avaliable

HSDB 419 Molecular Weight

197.841 g/mol

HSDB 419 Melting Point

No information avaliable

HSDB 419 H2O Solubility

No information avaliable

HSDB 419 State

Solid

HSDB 419 LogP

No information avaliable

HSDB 419 Dosage Forms

Tablet

HSDB 419 Indication

For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression

HSDB 419 Pharmacology

Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.

HSDB 419 Absorption

No information avaliable

HSDB 419 side effects and Toxicity

Symptoms of overdose include convulsions, muscle weakness and confusion.

HSDB 419 Patient Information

No information avaliable

HSDB 419 Organisms Affected

Humans and other mammals